COVID spike protein causing microcoltting is causing clotting, even in the absence of platelets in the blood. Paper is nominally dealing with COVID-19 infection, but since the jab produces the spike protein, there is no reason to presume that the jab doesn't have the same effect. But the age profile would be inverted, i.e. the natural infection hits the elderly and those with compromised immune system as their body is unable to fight it, but in healthy people, the jab uses the superior and more active metabolism of the young and healthy to produce vastly more spike protein than in older people. This is why mRNA vaccines/treatments are not suitable for wide use, the amount of the "therapeutic" that is delivered is dependent on the metabolism of the cells that it happens to get into. Get it into the wrong cells, or in a patient with a higher metabolism and you get problems. This, I think, is why the adverse reaction profile for the jabs is exponentially higher in the young, while the mortality is exponentially higher for the elderly and infirm. This is not something that is obscure or difficult to figure out. This research should have been done even prior to phase I trials, this should never have left the drawing board. The only conclusion is that it is all deliberate, the converse conclusion requires a chain of errors and coincidences that have a vanishingly small probability of occurring.